Phospholipase inhibitor, Rilapladib, Purity ≥98%

Synonym: 412950-08-4; SB 659032; SB659032; SB-659032; 2-[2-[(2,3-Difluorophenyl)methylsulfanyl]-4-oxoquinolin-1-yl]-N-[1-(2-methoxyethyl)piperidin-4-yl]-N-[[4-[4-(trifluoromethyl)phenyl]phenyl]methyl]acetamide; Phospholipase inhibitor

CAS Number: 412950-08-4
Compound CID: 9918381

Product Size

5 mg; 10 mg; 50 mg; 100 mg

Price

Datasheet

Datasheet

MSDS

MSDS

Properties

Description

Rilapladib is an effective metabolism inhibitor, that has the ability to prevent the pathway of cell metabolism by inhibiting phospholipases. The molecular weight of the compound is 735.81, and its molecular formula is C₄₀H₃₈F₅N₃O₃S.

Molecular Weight

735.81

Molecular Formula

C₄₀H₃₈F₅N₃O₃S

Form

Lyophilized powder

Purity

≥98%

Impurities

Free from inappropriate visible particulates, foreign matter, discoloration, or other defects.

Identity

Confirmed by NMR/HPLC/MS.

Applications

Rilapladib can be used for its potential to reduce cardiovascular risk by modulating inflammatory processes.